ZOMDF
Zomedica Corp.Company Information
- Company Name
- Zomedica Corp.
- CIK
- CIK0001684144
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- ZOMDF: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- ZOMDF
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-05-21
- Last sale
- —
- Shares purchased (TTM)
- 3,682,891
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2025-06-30
- Institutional shares owned
- 5,185,122
- Shares outstanding
- 979,949,668
- Ownership
- 0.53%
Earnings Market Reaction
- Filing date
- 2026-08-05
- Price on filing date
- —
- 1-month reaction
- -8.89%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 7 | 9 | 9 | 7 | 8 | 9 | 7 | 10 | 8 | 11 | 13 | 22 | ||||||
| Debt Securities Available For Sale Excluding Accrued Interest Current | 37 | 38 | 44 | 46 | 50 | 55 | 64 | 67 | 72 | 72 | 78 | 84 | ||||||
| Accounts Receivable Net Current | 6 | 4 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 1 | ||||||
| Inventory Net | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 6 | 5 | 5 | 4 | ||||||
| Prepaid Expense And Other Assets Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 3 | ||||||
| Other Receivables Net Current | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets Current | 58 | 60 | 64 | 65 | 69 | 73 | 82 | 87 | 89 | 92 | 100 | 115 | ||||||
| Prepaid Expense And Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 20 | 20 | 21 | 21 | 22 | 22 | 25 | 26 | 25 | 24 | 23 | 8 | ||||||
| Operating Lease Right Of Use Asset | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Goodwill | - | - | 0 | 0 | 0 | - | 46 | 46 | 46 | 62 | 62 | 74 | ||||||
| Intangible Assets Net Excluding Goodwill | 37 | 38 | 39 | 40 | 41 | 43 | 53 | 52 | 53 | 55 | 55 | 57 | ||||||
| Debt Securities Available For Sale Excluding Accrued Interest Noncurrent | - | - | - | 1 | 1 | 1 | - | 1 | 3 | 8 | 10 | 12 | ||||||
| Other Assets Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets | 118 | 122 | 127 | 131 | 136 | 143 | 207 | 214 | 220 | 244 | 253 | 275 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | - | - | - | - | - | - | - | - | - | 7 | 8 | 6 | ||||||
| Accrued Income Taxes | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Accounts Payable Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | - | 2 | - | ||||||
| Accrued Income Taxes Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Contract With Customer Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Liabilities Current | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Accrued Liabilities Current | 6 | 5 | 6 | 6 | 5 | 4 | 6 | 5 | 4 | - | 6 | - | ||||||
| Liabilities Current | 9 | 9 | 9 | 8 | 8 | 7 | 9 | 8 | 8 | 8 | 9 | 7 | ||||||
| Operating Lease Liability Noncurrent | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 1 | ||||||
| Deferred Income Tax Liabilities Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | ||||||
| Contract With Customer Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities | 11 | 11 | 12 | 11 | 11 | 11 | 12 | 11 | 11 | 12 | 13 | 14 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 381 | 381 | 381 | 381 | 381 | 381 | 381 | 381 | 381 | 381 | 381 | 381 | ||||||
| Additional Paid In Capital Common Stock | 34 | 34 | 34 | 34 | 33 | 33 | 33 | 32 | 32 | 31 | 30 | 29 | ||||||
| Retained Earnings Accumulated Deficit | -308 | -304 | -300 | -295 | -289 | -282 | -218 | -211 | -204 | -180 | -171 | -149 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | -0 | ||||||
| Stockholders Equity | 107 | 111 | 115 | 120 | 125 | 132 | 196 | 203 | 209 | 232 | 240 | 261 | ||||||
| Liabilities And Stockholders Equity | 118 | 122 | 127 | 131 | 136 | 143 | 207 | 214 | 220 | 244 | 253 | 275 | ||||||
| Common Stock No Par Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Shares Issued | 980 | 980 | 980 | 980 | 980 | 980 | 980 | 980 | 980 | 980 | 980 | 980 | ||||||
| Shares Outstanding | 980 | 980 | 980 | 980 | 980 | 980 | 980 | 980 | 980 | 980 | 980 | 980 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialZomedica Corp. (ZOMDF) — SEC Financial Statements & Analysis
Zomedica Corp. (ZOMDF) is a pharmaceutical preparations company, incorporated in A0. Zomedica Corp. trades on OTC as: ZOMDF. Zomedica Corp. (ZOMDF)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, Zomedica Corp. carries a market cap of $97.99M, a P/E ratio of -5.17x, a P/B ratio of 0.91x, a P/S ratio of 2.66x, an enterprise value of $90.80M, and an EV/EBITDA multiple of -4.86x. On profitability, it posts a gross margin of 65.44%, an operating margin of -56.28%, a net margin of -51.39%, a Return on Equity (ROE) of -16.29%, a Return on Assets (ROA) of -14.88%, and a Return on Invested Capital (ROIC) of -18.82%. Per share, it reports EPS of $-0.02, diluted EPS of $-0.08, free cash flow per share of $-0.01, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 30.05% year-over-year, net income growth of -77.73% year-over-year, and EPS growth of -77.73% year-over-year. On the balance sheet, it maintains a current ratio of 6.43x, a quick ratio of 5.57x, working capital of $48.89M, a debt-to-equity ratio of 0.10x, a debt ratio of 0.09, an interest coverage ratio of -65966.00x, free cash flow of $-13.67M (TTM), and net debt of $-7.19M. Figures sourced from SEC EDGAR.
- Market Cap
- $97.99M
- P/E TTM
- -5.17x
- EPS TTM
- $-0.02
- P/B TTM
- 0.91x
- ROE TTM
- -16.29%
- ROA TTM
- -14.88%
- Debt To Equity
- 0.10x
- Free Cash Flow TTM
- $-13.67M
- Net Revenue TTM Growth 1Y
- 30.05%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Zomedica Corp. in?
Zomedica Corp. (ZOMDF) operates in the Pharmaceutical Preparations industry.
What exchange does ZOMDF trade on?
Zomedica Corp. (ZOMDF) trades on the OTC.
Where is Zomedica Corp. incorporated?
Zomedica Corp. is incorporated in Alberta, Canada.
When was Zomedica Corp. (ZOMDF)'s most recent SEC filing?
Zomedica Corp. (ZOMDF)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05.
What is ZOMDF's market cap?
Zomedica Corp. (ZOMDF) has a market capitalization of $97.99M as of 2026-06-30.
What is ZOMDF's EPS (earnings per share)?
Zomedica Corp. (ZOMDF)'s trailing twelve month EPS is $-0.02 as of 2026-06-30.
What is ZOMDF's ROE (return on equity)?
Zomedica Corp. (ZOMDF)'s trailing twelve month Return on Equity (ROE) is -16.29% as of 2026-06-30.
What is ZOMDF's ROA (return on assets)?
Zomedica Corp. (ZOMDF)'s trailing twelve month Return on Assets (ROA) is -14.88% as of 2026-06-30.
What is ZOMDF's ROIC (return on invested capital)?
Zomedica Corp. (ZOMDF)'s trailing twelve month Return on Invested Capital (ROIC) is -18.82% as of 2026-06-30.
What is ZOMDF's EV/EBITDA?
Zomedica Corp. (ZOMDF)'s trailing twelve month EV/EBITDA is -4.86x as of 2026-06-30.